
|Videos|April 24, 2017
Biosimilars in Specialty Pharmacy
Author(s)Lauren Santye, Assistant Editor
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses the potential impact of biosimilars on specialty pharmacy.
Advertisement
Suzette DiMascio, CHE, CMCE, CPC, president and CEO of CSI Specialty Group, discusses the potential impact of biosimilars on specialty pharmacy.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Semaglutide Shows Direct Organ-Protective Benefits Beyond Weight Loss in HFpEF
2
November 2025 Pharmacy Policy Updates
3
Immune Synergy May Explain Why Some Patients Achieve Durable Remission With Cilta-Cel
4
Neladalkib Shows Durable Responses in Heavily Pretreated ALK-Positive Lung Cancer
5















































































































































































































